Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
PRISM BioLab, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.
[Summary] Financial Results for the Year
Eisai to Present Clinical Trial and Biomarker Exploration Results of E7386, Co-Created with PRISM BioLab, at the ESMO Annual Congress
Notice Regarding the Termination of the Collaboration & License Option Agreement with Servier
PRISM BioLab, Oct-Jun (Cumulative 3Q) Ordinary Profit Loss Widens, Apr-Jun Ordinary Profit Loss Widens
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO(American Society of Clinical Oncology) Annual Meeting
PRISM BioLab, First Half Ordinary Profit Loss Widens, Jan-Mar Ordinary Profit Loss Widens
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug
PRISM BioLab, Oct-Dec (1Q) Ordinary Profit Loss Widens
PRISM BioLab Co.,LTD, Last Fiscal Year's Net Income Loss Widens, Current period performance is undisclosed.